MaryO
-
Posts
8,082 -
Joined
-
Last visited
-
Days Won
556
MaryO's Achievements
Single Status Update
-
“We are pursuing a drug that has a very real potential to become the optimal agent of choice and a standard of care for these Cushing’s patients,” said Manohar Katakam Ph. D., CEO of SteroTherapeutics. "Our clinical trial will target multiple critical metabolic-related outcomes including the reduction of triglycerides, insulin resistance, weight loss, and the prevention and/or abrogation of hepatic steatosis and fibrosis.”
Read more at https://cushieblog.com/2018/04/04/sterotherapeutics-receives-fda-orphan-drug-designation/
